HIV

Gilead, Aelix ally to trial HIV-suppressing combination
Fierce Biotech
Thu, 10/18/18 - 11:20 am
Gilead Sciences
Aelix Therapeutics
vaccines
antiretrovirals
HIV
Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study
Pharmaceutical Business Review
Thu, 10/4/18 - 09:42 am
Gilead Sciences
Biktarvy
HIV-1
HIV
Why Payers Sometimes Restrict Access To Single Tablet Regimens For HIV Patients
Forbes
Mon, 10/1/18 - 09:45 am
HIV
antiretrovirals
payers
T-cell therapy for eradicating HIV reservoirs proves safe in small study
Fierce Biotech
Sat, 09/22/18 - 05:29 pm
HIV
immunotherapy
What's Next for Gilead Sciences After Its Latest Clinical Success
Motley Fool
Thu, 09/13/18 - 12:00 pm
Gilead Sciences
John Milligan
HIV
NASH
filgotinib
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Fierce Pharma
Mon, 09/10/18 - 11:00 pm
drug development
vaccines
HIV
tuberculosis
malaria
FDA approves two new HIV drugs from Merck
Reuters
Fri, 08/31/18 - 10:57 am
Merck
HIV
FDA
Delstrigo
Pifeltro
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Thu, 08/16/18 - 10:09 am
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
Long-acting injection boosts hopes for GSK's HIV business
Yahoo/Reuters
Wed, 08/15/18 - 09:40 am
GSK
HIV
AIDS
cabotegravir
rilpivirine
ViiV
AIDS health group brings Gilead patent skirmish to Supreme Court
Fierce Pharma
Tue, 08/14/18 - 11:57 am
Gilead Sciences
AIDS
HIV
TAF
Supreme Court
Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It
Forbes
Tue, 08/7/18 - 11:42 pm
Gilead Sciences
HIV
Truvada
drug ads
Express Scripts to Drop Big Sellers From AbbVie, Gilead in 2019
Bloomberg
Tue, 08/7/18 - 11:24 am
Express Scripts
PBMs
Gilead Sciences
HIV
Atripla
AbbVie
Mavyret
hepatitis C
China Approves Gilead's Genvoya for HIV-1 Infection
CP Wire
Mon, 08/6/18 - 09:47 am
Gilead Sciences
China
Genvoya
HIV
China Approves Gilead's Genvoya for HIV-1 Infection
Mon, 08/6/18 - 09:35 am
Gilead Sciences
Genvoya
HIV
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
CP Wire
Tue, 07/24/18 - 10:11 am
Merck
Doravirine
HIV
Gilead Announces Data on Truvada for HIV Prophylaxis
CP Wire
Tue, 07/24/18 - 12:47 pm
Gilead Sciences
Truvada
HIV
Merck Announces Data from Ph III Study of Investigational HIV Therapy Doravirine
Tue, 07/24/18 - 09:55 am
Merck
Doravirine
HIV
Gilead Announces Data on Truvada for HIV Prophylaxis
Tue, 07/24/18 - 12:47 pm
Gilead Sciences
HIV
Truvada
Where does J&J's new drug fit in the crowded HIV market?
Biopharma Dive
Wed, 07/18/18 - 09:54 pm
JNJ
Janssen
FDA
HIV
Symtuza
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
Mon, 07/16/18 - 09:21 am
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay

Pages